Georgia lawmakers are exploring the potential of psychedelics in treating veterans' mental health challenges, marking a significant shift in the state's traditionally conservative stance on drug policy. As Medical Xpress reported, a bipartisan panel has recommended allocating up to $5 million to study the therapeutic effects of substances like MDMA and psilocybin on post-traumatic stress disorder (PTSD) and traumatic brain injuries in veterans.
A Promising, Yet Controversial Step
The recommendation is part of 16 proposals from the Senate Study Committee on Veterans, Mental Health and Housing. While funding must still be approved by the Georgia General Assembly, the panel's endorsement reflects growing interest in alternative therapies for PTSD, a condition disproportionately affecting veterans. Symptoms such as ...